Press Release Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Aug 12
Press Release Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylmâ„¢ (dibutepinephrine) Sublingual Film Aug 10
Press Release Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Jul 29